top of page

Menveo Powder and Solution for Solution for Injection

Product details

Registration number: SIN14083P

Classification: Prescription Only

Active ingredients:

  • (MenA Lyo) Meningococcal Group A oligosaccharide conjugated to CRM197 protein
  • (MenCWY) Meningococcal Group C oligosaccharide conjugated to CRM197 protein
  • (MenCWY) Meningococcal Group W-135 oligosaccharide conjugated to CRM197 protein
  • (MenCWY) Meningococcal Group Y oligosaccharide conjugated to CRM197 protein

Strength:

  • 10 microgram conjugated to 16.7-33.3 microgram
  • 5 microgram conjudated to 7.1-12.5 microgram
  • 5 microgram conjugated to 3.3-8.3 microgram
  • 5 microgram conjugated to 5.6-10 microgram

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAMUSCULAR

Registrant: GLAXOSMITHKLINE PTE LTD

ATC code: J07AH08

HSA approval date: 20 January 2012

Manufacturer(s):

  • GSK Vaccines S.r.l. (MenCWY Liquid)
  • PATHEON ITALIA S.P.A. (MenA Lyo)

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for Menveo Powder and Solution for Solution for Injection?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14083P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Menveo Powder and Solution for Solution for Injection?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • (MenA Lyo) Meningococcal Group A oligosaccharide conjugated to CRM197 protein
  • (MenCWY) Meningococcal Group C oligosaccharide conjugated to CRM197 protein
  • (MenCWY) Meningococcal Group W-135 oligosaccharide conjugated to CRM197 protein
  • (MenCWY) Meningococcal Group Y oligosaccharide conjugated to CRM197 protein

Strength:

  • 10 microgram conjugated to 16.7-33.3 microgram
  • 5 microgram conjudated to 7.1-12.5 microgram
  • 5 microgram conjugated to 3.3-8.3 microgram
  • 5 microgram conjugated to 5.6-10 microgram

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Menveo Powder and Solution for Solution for Injection?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for Menveo Powder and Solution for Solution for Injection?

According to the HSA dataset updated 7 August 2026:

Registrant: GLAXOSMITHKLINE PTE LTD

Source for this answer

Which manufacturers and countries are listed for Menveo Powder and Solution for Solution for Injection?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • GSK Vaccines S.r.l. (MenCWY Liquid)
  • PATHEON ITALIA S.P.A. (MenA Lyo)

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up Menveo Powder and Solution for Solution for Injection in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14083P or the exact product name Menveo Powder and Solution for Solution for Injection. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Menveo Powder and Solution for Solution for Injection record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Menveo Powder and Solution for Solution for Injection record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14083P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page